This study evaluated whether blood pressure levels change throughout the day. 

This study looked at risk factors that may hinder blood pressure control in patients with high blood pressure and coronary heart disease. 

The current study explores the effect on kidney function of baroreflex activation therapy, a treatment for high blood pressure (hypertension).

This study investigated if hydrochlorothiazide and alternative thiazide-type diuretics (CHIPs) can treat left ventricular hypertrophy (LVH) in patients with hypertension. They found that CHIPs effectively treat LVH in patients with hypertension.

This study investigated if intermittent attempts to healthy eating improved cardiovascular disease (CVD) risk factors. They found that healthy eating reduced CVD risk factors.

This study investigated the long-term effects of blood pressure-lowering treatment (BP-LT) and lipid-lowering treatment (L-LT) in the management of hypertension. They found that BP-LT and L-LT improved survival rates in patients with hypertension.

This study investigated if self-monitoring of blood pressure (BP) improves BP control in patients with hypertension. They found that self-monitoring results in improved BP levels and BP control at 12 months.

This study investigated if the use of blood pressure (BP)-interfering medication is common in patients hypertension. The study concluded that patients with new or treatment-resistant hypertension commonly take BP-interfering medication including non-steroidal anti-inflammatory drugs (NSAIDs).

This study examined the effects of hormone levels on treatment with tadalafil (Cialis) for erectile dysfunction in men with benign prostatic hyperplasia (BPH). Authors concluded that tadalafil improved erectile function in men with BPH regardless of hormone levels before treatment.

This study investigated a fixed-dose combination of amlodipine and valsartan (AML/VAL) for the treatment of hypertension.

They found that AML/VAL reduced blood pressure in patients with poor response to VAL alone.